Jin SHI,Zengmiao HOU,En GAO,Xiaoying LI,Xiaolin YANG,Jinli ZHAO
申请号：
HK18113908
公开号：
HK1252301A2
申请日:
2018.10.31
申请国别(地区):
HK
年份:
2019
代理人:
摘要：
The present invention provides a kind of novel artificial tear containing recombinant human lysozyme. The novel artificial tear includes principal component and auxiliary material, and the principal component is recombinant human lysozyme and Sodium Hyaluronate, and in terms of the gross mass of novel artificial tear, the content of recombinant human lysozyme and Sodium Hyaluronate is respectively 0.075%-0.300%, 0.10%-0.30%. The present invention is effectively combined recombinant human lysozyme, Sodium Hyaluronate with auxiliary material, it is administered by eye external drug, eye lacrimal secretion caused by light, moderate universe eye disease is declined, the eye universe is puckery, light inflammation, slight angle conjunctival damage etc. have apparent treatment improvement result.本發明提供了一種含有重組人溶菌酶的新型人工淚液。該新型人工淚液包括主成分和輔料，所述主成分為重組人溶菌酶和透明質酸鈉，以新型人工淚液的總質量計，重組人溶菌酶和透明質酸鈉的含量分別為0.075%-0.300%、0.10%-0.30%。本發明將重組人溶菌酶、透明質酸鈉與輔料有效結合，經過眼部外用藥物給藥，對輕、中度乾眼症引起的眼部淚液分泌量下降，眼部乾澀，輕微炎症，輕度角結膜損傷等有明顯的治療改善作用。
